Headline:
Why Doesn't the Surgeon General Seek FDA Reclassification of Naloxone to OTC?
Publication Date:
Wednesday, April 18, 2018
Primary Source:
Type:
article
Format:
Newspaper (Online)
Nature of Mention:
authored
Scholar:
Research Area:
Subjects:
Attached Files:
Custom Description:
Cato@Liberty post authored by Jeffrey A. Singer on deregulating naxolone re-printed at In Defense of Liberty (Goldwater Institute): "Why Doesn't the Surgeon General Seek FDA Reclassification of Naloxone to OTC?"